Insider Transactions in Q2 2021 at Precision Biosciences Inc (DTIL)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 23
2021
|
David S. Thomson Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
30,000
-21.2%
|
$300,000
$10.65 P/Share
|
|
Jun 23
2021
|
David S. Thomson Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+17.49%
|
$30,000
$1.18 P/Share
|
|
Jun 21
2021
|
David S. Thomson Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
15,000
-11.86%
|
$150,000
$10.77 P/Share
|
|
Jun 21
2021
|
David S. Thomson Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+10.6%
|
$15,000
$1.18 P/Share
|
|
Jun 18
2021
|
David S. Thomson Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-8.23%
|
$110,000
$11.0 P/Share
|
|
Jun 18
2021
|
David S. Thomson Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+7.6%
|
$10,000
$1.18 P/Share
|
|
Jun 17
2021
|
David S. Thomson Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-8.23%
|
$100,000
$10.44 P/Share
|
|
Jun 17
2021
|
David S. Thomson Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+7.6%
|
$10,000
$1.18 P/Share
|
|
Jun 15
2021
|
David S. Thomson Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,858
-2.5%
|
$31,438
$11.2 P/Share
|
|
Jun 15
2021
|
David S. Thomson Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,858
+2.44%
|
$2,858
$1.18 P/Share
|
|
Jun 11
2021
|
David S. Thomson Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
30,000
-21.2%
|
$330,000
$11.52 P/Share
|
|
Jun 11
2021
|
David S. Thomson Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+17.49%
|
$30,000
$1.18 P/Share
|
|
May 17
2021
|
Derek Jantz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
20,000
-0.49%
|
$180,000
$9.38 P/Share
|
|
May 14
2021
|
Derek Jantz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
9,673
-0.24%
|
$87,057
$9.17 P/Share
|
|
May 14
2021
|
Derek Jantz Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,514
+0.53%
|
$0
$0.04 P/Share
|
|
May 13
2021
|
Matthew R. Kane President and CEO |
SELL
Open market or private sale
|
Direct |
9,675
-0.48%
|
$77,400
$8.96 P/Share
|
|
May 13
2021
|
Matthew R. Kane President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,514
+1.05%
|
$0
$0.04 P/Share
|
|
May 13
2021
|
Derek Jantz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
9,673
-0.24%
|
$87,057
$9.15 P/Share
|
|
May 13
2021
|
Derek Jantz Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,514
+0.53%
|
$0
$0.04 P/Share
|
|
May 12
2021
|
Derek Jantz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
9,676
-0.24%
|
$77,408
$8.72 P/Share
|
|
May 12
2021
|
Derek Jantz Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,514
+0.53%
|
$0
$0.04 P/Share
|
|
May 10
2021
|
Matthew R. Kane President and CEO |
SELL
Open market or private sale
|
Direct |
9,746
-0.48%
|
$77,968
$8.25 P/Share
|
|
May 10
2021
|
Matthew R. Kane President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,514
+1.06%
|
$0
$0.04 P/Share
|
|
May 07
2021
|
Matthew R. Kane President and CEO |
SELL
Open market or private sale
|
Direct |
9,742
-0.49%
|
$77,936
$8.57 P/Share
|
|
May 07
2021
|
Matthew R. Kane President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,514
+1.06%
|
$0
$0.04 P/Share
|
|
Apr 21
2021
|
Matthew R. Kane President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,422
+0.67%
|
$13,422
$1.18 P/Share
|
|
Apr 19
2021
|
Derek Jantz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
9,676
-0.24%
|
$77,408
$8.69 P/Share
|
|
Apr 19
2021
|
Derek Jantz Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,514
+0.53%
|
$0
$0.04 P/Share
|
|
Apr 16
2021
|
Derek Jantz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
9,675
-0.24%
|
$77,400
$8.84 P/Share
|
|
Apr 16
2021
|
Derek Jantz Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,514
+0.53%
|
$0
$0.04 P/Share
|
|
Apr 15
2021
|
Derek Jantz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
9,676
-0.24%
|
$77,408
$8.76 P/Share
|
|
Apr 15
2021
|
Derek Jantz Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,514
+0.53%
|
$0
$0.04 P/Share
|
|
Apr 12
2021
|
Matthew R. Kane President and CEO |
SELL
Open market or private sale
|
Direct |
9,741
-0.49%
|
$77,928
$8.67 P/Share
|
|
Apr 12
2021
|
Matthew R. Kane President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,514
+1.08%
|
$0
$0.04 P/Share
|
|
Apr 09
2021
|
Matthew R. Kane President and CEO |
SELL
Open market or private sale
|
Direct |
9,737
-0.5%
|
$77,896
$8.87 P/Share
|
|
Apr 09
2021
|
Matthew R. Kane President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,514
+1.08%
|
$0
$0.04 P/Share
|
|
Apr 08
2021
|
Matthew R. Kane President and CEO |
SELL
Open market or private sale
|
Direct |
9,736
-0.5%
|
$87,624
$9.0 P/Share
|
|
Apr 08
2021
|
Matthew R. Kane President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,514
+1.09%
|
$0
$0.04 P/Share
|